USANA Health Sciences, Inc.’s (USNA) share price has entered into oversold territory with a stochastic value of 16.211. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 19 cents over the past month to $4.39 per share. USANA Health Sciences, Inc. is a Zacks #1 Rank (“Strong Buy”) company.
USANA HEALTH SCIENCES INC (USNA): Free Stock Analysis Report
More From Zacks.com
Finance expert Suze Orman has voiced concerns about the impact of climate change on property insurance costs, asserting it could threaten the American dream of homeownership. Orman, 72, faced a $28,000 annual insurance quote for her Florida oceanside condo, leading her to forego coverage entirely. She highlights a troubling trend where soaring insurance costs driven by frequent and severe weather events may deter Americans from buying homes. Don't Miss: For many first-time buyers, a house is abo
In early 2021, Ark Invest, led by tech investor Cathie Wood, managed a staggering $59 billion across six funds, making it the world’s largest active ETF manager. Three years later, a significant 80% downturn occurred, with assets under management in those funds plummeting to just $11.1 billion. This decline can be attributed to a combination of factors, including high interest rates dampening Wood’s long-term speculative tech investments and the subsequent wave of outflows from disillusioned inv
After Congress approved billions of extra funding for tax compliance, the Internal Revenue Service pledged it would get tougher on rich taxpayers and corporations while avoiding extra scrutiny of middle-class households.
After a dismal quarter for Tesla, CEO Elon Musk tried to reassure investors the company’s real value was its effort to perfect self-driving cars.
Six teams managing nearly $15 billion in total assets quit JPMorgan Chase’s brokerage unit to join competitors last Friday. Here’s what may have triggered their departures.
Billionaire investors are ditching the "infrastructure backbone" of the artificial intelligence (AI) revolution in favor of two industry-leading, irreplaceable AI stocks.
When it comes to reliable passive income, these three dividend-paying companies are best in breed.
CEO Larry Ellison said the relocation will help the company better integrate with the healthcare industry.
This up-and-coming digital bank is ready to start generating outsized profits.
The premier name among retail REITs, along with a 14%-yielding REIT that's returned $25 billion to its shareholders since going public, make for sensational buys right now.